Haemonetics (HAE) Tops Q3 EPS by 4c, Revenues Miss; Offers FY19 EPS Mid-Point Guidance Below Consensus

Go back to Haemonetics (HAE) Tops Q3 EPS by 4c, Revenues Miss; Offers FY19 EPS Mid-Point Guidance Below Consensus

Haemonetics 3rd Quarter Fiscal 2019 Earnings Release Available on Investor Relations Website

February 5, 2019 6:00 AM EST

BRAINTREE, Mass., Feb. 5, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that its third quarter and year-to-date fiscal 2019 results ended December 29, 2018 are available on its Investor relations website.

The... More